Gara Jalqabaatti › Dhibee Autoimmune › New York › New York City
Qorannoo klinikaalii Dhibee Autoimmune New York City, NY keessatti
Qorannoo 19 Dhibee Autoimmune f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Memorial Sloan Kettering Cancer Center, New York
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
Daratumumab in Primary Antiphospholipid Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
- NYU Langone, New York
- Hospital for Special Surgery, New York
- Weill Cornell, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Icahn School of Medicine at Mount Sinai, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Abatacept for the Treatment of Giant Cell Arteritis
Namoota walitti qabaa jiraSadarkaa 3
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Namoota walitti qabaa jiraSadarkaa 3
- Icahn School of Medicine at Mount Sinai, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 2/3
- Columbia University Irving Medical Center, New York
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Namoota walitti qabaa jiraSadarkaa 1/2
- Columbia University, New York
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Namoota walitti qabaa jiraSadarkaa 3
- Site Number - 1036, New York
- Site Number - 1034, New York
Autoimmune and Autoinflammatory Genetics Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- fi 3 dabalataa
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Namoota walitti qabaa jiraSadarkaa 1/2
- Columbia University, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Montefiore Medical Center, New York
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Namoota walitti qabaa jiraSadarkaa 1
- Columbia University Irving Medical Center, New York
Biologics And Clinical Immunology Cohort at Sinai
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mount Sinai, New York
Allergy and Immunology Natural History Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Qorannoo Dhibee Autoimmune magaalota biroo keessatti
- Houston, TXQorannoo 21
- Washington, DCQorannoo 19
- Philadelphia, PAQorannoo 16
- Durham, NCQorannoo 15
- Boston, MAQorannoo 13
- Chicago, ILQorannoo 12
- Los Angeles, CAQorannoo 12
- Dallas, TXQorannoo 9
- Atlanta, GAQorannoo 8
- Portland, ORQorannoo 8
- Milwaukee, WIQorannoo 8
- Cleveland, OHQorannoo 8
Qorannoo biroo New York City keessatti
- Saree OljooQorannoo 136
- Kansara Qara'a Non-Small CellQorannoo 121
- Saree (Gosoota Hunda)Qorannoo 109
- Kansarii ProstateQorannoo 103
- Kansara MetastatikiiQorannoo 93
- Kansarii ColorectalQorannoo 78
- Kansarii OvariiQorannoo 69
- Dhibee QaraQorannoo 60
- Myeloma Baay’eeQorannoo 60
- Kansarii PancreasQorannoo 60
- Kansa EndometiriyaaliiQorannoo 52
- Leukemia Myeloidii HamaaQorannoo 51
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.